Patents by Inventor Matthew LeBaron

Matthew LeBaron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220175822
    Abstract: Embodiments are directed towards methods of inducing caspase activity. The methods include contacting a cell with a treatment compound represented by the following Formula (I), where the treatment compound is a random copolymer, R1 is selected from hydrogen and a hydroxyl group, R2 is selected from hydrogen and a hydroxyl group, R1 is different than R2, and a sum of x and y is from 4 to 20,000.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 9, 2022
    Applicant: Dow Global Technologies LLC
    Inventors: Caroline Woelfle-Gupta, Andrew Scott, Matthew LeBaron, Daniel Wilson, Susan L. Jordan, Robert L. Schmitt, Raja Settivari
  • Publication number: 20220125830
    Abstract: Embodiments are directed towards methods of inducing caspase activity. The methods include contacting a cell with a treatment compound formed by alkoxylation of an initiator using an oxide.
    Type: Application
    Filed: February 26, 2020
    Publication date: April 28, 2022
    Applicant: Dow Global Technologies LLC
    Inventors: Caroline Woelfle-Gupta, Andrew Scott, Matthew LeBaron, Daniel Wilson, Susan L. Jordan, Robert L. Schmitt, Raja Settivari
  • Publication number: 20220054534
    Abstract: Embodiments are directed towards methods of inducing caspase activity. The methods include contacting a cell with a treatment compound represented by the following Formula (I): where R1 is selected from hydrogen or an alkyl group having from 1 to about 16 carbon atoms; R2 is selected from a hydroxyl group, a tosylate group, an alkoxy group of the formula OR3 where R3 is selected from an alkyl group having from 1 to about 16 carbon atoms, or an ester group of the formula OCOR4, where R4 is an alkyl group having from 1 to about 16 carbon atoms, and n is from 4 to 46,000, with the proviso that when R1 is hydrogen and R2 is a hydroxy group the treatment compound has a number average molecular weight from 10,100 to 2,000,0000 g/mol.
    Type: Application
    Filed: February 26, 2020
    Publication date: February 24, 2022
    Applicant: Dow Global Technologies LLC
    Inventors: Caroline Woelfle-Gupta, Andrew Scott, Matthew LeBaron, Daniel Wilson, Susan L. Jordan, Robert L. Schmitt, Raja Settivari
  • Publication number: 20060257908
    Abstract: The present invention relates to a method for creating two- and three-dimensional arrays. Plates of sample materials are stacked to create primary stacks. Primary stacks are sliced to form combs. Combs are stacked to form secondary stacks. Secondary stacks are sliced to form tertiary plates or two-dimensional arrays. Tertiary plates can be stacked to form three-dimensional arrays. The two- and three-dimensional arrays can be used in large-scale parallel processing of samples, pattern printing, tissue engineering, microfluidics, microelectronics, and microconstruction.
    Type: Application
    Filed: April 24, 2006
    Publication date: November 16, 2006
    Applicant: Georgetown University
    Inventors: Hallgeir Rui, Matthew LeBaron